{"id":93244,"date":"2026-05-20T18:01:26","date_gmt":"2026-05-20T12:31:26","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=93244"},"modified":"2026-05-20T18:01:27","modified_gmt":"2026-05-20T12:31:27","slug":"eris-lifesciences-q4-fy26-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/","title":{"rendered":"Eris Lifesciences Q4 FY26 Results: PAT Rs 280 Cr"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p><strong><a href=\"https:\/\/univest.in\/user\/stocks\/eris\/eris-lifesciences-ltd-share-price-today\">Eris Lifesciences<\/a> Q4 FY26<\/strong> results were declared on May 20, 2026. Eris Lifesciences reported PAT of Rs 280 crore for the quarter ended March 31, 2026, up 174% YoY compared to Rs 102 crore in Q4 FY25. Revenue from operations stood at Rs 757 crore, up 7% YoY. Gross profit was Rs 204 crore (up 16% YoY). The results are on a Consolidated basis. Eris Lifesciences is a Branded Pharmaceuticals company listed on Indian stock exchanges.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\">Click Here \u2013 Get Free Investment Predictions<\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/#Eris_Lifesciences_Q4_FY26_Financial_Highlights\" title=\"Eris Lifesciences Q4 FY26 Financial Highlights\">Eris Lifesciences Q4 FY26 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/#Eris_Lifesciences_Q4_FY26_Performance_Analysis\" title=\"Eris Lifesciences Q4 FY26 Performance Analysis\">Eris Lifesciences Q4 FY26 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/#Key_Factors_Driving_Eris_Lifesciences_Q4_FY26_Results\" title=\"Key Factors Driving Eris Lifesciences Q4 FY26 Results\">Key Factors Driving Eris Lifesciences Q4 FY26 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/#Revenue_Performance_in_Q4_FY26\" title=\"Revenue Performance in Q4 FY26\">Revenue Performance in Q4 FY26<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/#Profitability_and_Margin_Trends\" title=\"Profitability and Margin Trends\">Profitability and Margin Trends<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/#India_Macro_Tailwinds_in_Q4_FY26\" title=\"India Macro Tailwinds in Q4 FY26\">India Macro Tailwinds in Q4 FY26<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/#FY27_Outlook_for_Eris_Lifesciences\" title=\"FY27 Outlook for Eris Lifesciences\">FY27 Outlook for Eris Lifesciences<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/#Frequently_Asked_Questions_on_Eris_Lifesciences_Q4_FY26\" title=\"Frequently Asked Questions on Eris Lifesciences Q4 FY26\">Frequently Asked Questions on Eris Lifesciences Q4 FY26<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/#What_is_Eris_Lifesciences_Q4_FY26_net_profit\" title=\"What is Eris Lifesciences Q4 FY26 net profit?\">What is Eris Lifesciences Q4 FY26 net profit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/#What_is_Eris_Lifesciences_Q4_FY26_revenue\" title=\"What is Eris Lifesciences Q4 FY26 revenue?\">What is Eris Lifesciences Q4 FY26 revenue?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/#When_were_Eris_Lifesciences_Q4_FY26_results_declared\" title=\"When were Eris Lifesciences Q4 FY26 results declared?\">When were Eris Lifesciences Q4 FY26 results declared?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/eris-lifesciences-q4-fy26-results\/#Is_Eris_Lifesciences_a_good_investment_after_Q4_FY26_results\" title=\"Is Eris Lifesciences a good investment after Q4 FY26 results?\">Is Eris Lifesciences a good investment after Q4 FY26 results?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Eris_Lifesciences_Q4_FY26_Financial_Highlights\"><\/span><strong>Eris Lifesciences Q4 FY26 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q4 FY26 (Rs Cr)<\/th>\n<th>Q4 FY25 (Rs Cr)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>757<\/td>\n<td>705<\/td>\n<td>+7%<\/td>\n<\/tr>\n<tr>\n<td><strong>Gross Profit<\/strong><\/td>\n<td>204<\/td>\n<td>175<\/td>\n<td>+16%<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit<\/strong><\/td>\n<td>280<\/td>\n<td>102<\/td>\n<td>+174%<\/td>\n<\/tr>\n<tr>\n<td><strong>Basis<\/strong><\/td>\n<td colspan=\"3\">Consolidated<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Note: Exceptional quarter: PAT surged 174% YoY to Rs 280 crore on revenue of Rs 757 crore (+7% YoY). Gross profit +16% to Rs 204 crore. Eris Lifesciences Q4 FY26 results declared May 20, 2026. Verify from BSE\/NSE audited filings.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Eris_Lifesciences_Q4_FY26_Performance_Analysis\"><\/span><strong>Eris Lifesciences Q4 FY26 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Eris Lifesciences Q4 FY26<\/strong> results reflect the company&#8217;s operational performance in the January to March 2026 quarter. The quarter demonstrates a meaningful improvement in profitability. Eris Lifesciences operates in the Branded Pharmaceuticals space, a sector shaped by domestic consumption trends, input costs, and India&#8217;s macro environment in FY26.<\/p>\n<p>The 174% YoY PAT growth in Eris Lifesciences Q4 FY26 reflects operational improvements, better cost management, and revenue scale benefits.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\">Screen the best stocks on the Univest Screener.<\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Factors_Driving_Eris_Lifesciences_Q4_FY26_Results\"><\/span><strong>Key Factors Driving Eris Lifesciences Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Performance_in_Q4_FY26\"><\/span><strong>Revenue Performance in Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Eris Lifesciences Q4 FY26 revenue of Rs 757 crore was up 7% YoY. Revenue was broadly stable, reflecting a steady operating environment for the Branded Pharmaceuticals business.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Profitability_and_Margin_Trends\"><\/span><strong>Profitability and Margin Trends<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Eris Lifesciences Q4 FY26 PAT of Rs 280 crore (up 174% YoY) reflects strong operating leverage and margin expansion in the Branded Pharmaceuticals business.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"India_Macro_Tailwinds_in_Q4_FY26\"><\/span><strong>India Macro Tailwinds in Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The January to March 2026 quarter benefited from India&#8217;s GDP growth above 6.5%, strong government capital expenditure, and resilient urban and rural consumption. The RBI&#8217;s accommodative policy stance supported demand conditions across consumer and industrial sectors. For Eris Lifesciences, operating in the Branded Pharmaceuticals space, this macro environment provided a constructive demand backdrop during the quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Outlook_for_Eris_Lifesciences\"><\/span><strong>FY27 Outlook for Eris Lifesciences<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Following Eris Lifesciences Q4 FY26 results, investors will track management commentary on FY27 revenue guidance, margin trajectory, capex plans, and competitive positioning. The Branded Pharmaceuticals sector continues to benefit from India&#8217;s structural growth story, rising middle-class consumption, and infrastructure investment cycle.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to get daily stock recommendations and expert research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Eris_Lifesciences_Q4_FY26\"><\/span><strong>Frequently Asked Questions on Eris Lifesciences Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div>\n<div>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Eris_Lifesciences_Q4_FY26_net_profit\"><\/span><strong>What is Eris Lifesciences Q4 FY26 net profit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div>\n<p><strong>Ans.<\/strong> <strong>Eris Lifesciences Q4 FY26<\/strong> PAT of Rs 280 crore, up 174% YoY from Rs 102 crore in Q4 FY25. Results declared May 20, 2026, on a Consolidated basis.<\/p>\n<\/div>\n<\/div>\n<div>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Eris_Lifesciences_Q4_FY26_revenue\"><\/span><strong>What is Eris Lifesciences Q4 FY26 revenue?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div>\n<p><strong>Ans.<\/strong> Eris Lifesciences Q4 FY26 revenue from operations was Rs 757 crore, up 7% YoY. Gross profit was Rs 204 crore (up 16% YoY).<\/p>\n<\/div>\n<\/div>\n<div>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Eris_Lifesciences_Q4_FY26_results_declared\"><\/span><strong>When were Eris Lifesciences Q4 FY26 results declared?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div>\n<p><strong>Ans.<\/strong> Eris Lifesciences Q4 FY26 results were declared on May 20, 2026, at the board of directors meeting approving audited financial statements for Q4 and full-year FY26.<\/p>\n<\/div>\n<\/div>\n<div>\n<h3><span class=\"ez-toc-section\" id=\"Is_Eris_Lifesciences_a_good_investment_after_Q4_FY26_results\"><\/span><strong>Is Eris Lifesciences a good investment after Q4 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div>\n<p><strong>Ans.<\/strong> Investment decisions require individual assessment of fundamentals, valuation, risk tolerance, and investment horizon. This article is for educational purposes. Consult a SEBI-registered financial advisor before investing in Eris Lifesciences.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Verify all figures from BSE\/NSE filings. Consult a SEBI-registered financial advisor.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eris Lifesciences Q4 FY26 results declared May 20 2026. PAT of Rs 280 crore up 174% YoY. Revenue Rs 757 crore up 7% YoY. Full analysis.<\/p>\n","protected":false},"author":26,"featured_media":93306,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-93244","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1779280303:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["75"],"rank_math_focus_keyword":["Eris Lifesciences Q4"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Eris Lifesciences Q4 FY26 Results: PAT Rs 280 Cr"],"rank_math_description":["Eris Lifesciences Q4 FY26 results declared May 20 2026. PAT of Rs 280 crore up 174% YoY. Revenue Rs 757 crore up 7% YoY. Full analysis."],"_thumbnail_id":["93306"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["12588"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/20180102\/Eris-Lifesciences-Q4-FY26-Results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/93244","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=93244"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/93244\/revisions"}],"predecessor-version":[{"id":93307,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/93244\/revisions\/93307"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/93306"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=93244"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=93244"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=93244"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}